China Biologic Products (CBPO) Short Interest Ratio & Short Volume

Short interest is the volume of China Biologic Products shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 601,500 shares of CBPO short. 1.72% of China Biologic Products' shares are currently sold short. Learn More on China Biologic Products' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CBPO shares currently have a short interest ratio of 4.0. Learn More on China Biologic Products's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.72% of China Biologic Products' floating shares are currently sold short.

China Biologic Products saw a decrease in short interest in April. As of April 15th, there was short interest totaling 601,500 shares, a decrease of 23.0% from the previous total of 781,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

China Biologic Products currently has issued a total of 39,360,000 shares. Some of China Biologic Products' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China Biologic Products currently has a public float of 34,880,000 shares.

1.72% of China Biologic Products' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to China Biologic Products: CRISPR Therapeutics AG (17.39%), Krystal Biotech, Inc. (7.61%), Halozyme Therapeutics, Inc. (6.28%), Immunovant, Inc. (14.92%), ImmunityBio, Inc. (41.52%), Revolution Medicines, Inc. (7.29%), Iovance Biotherapeutics, Inc. (21.08%), SpringWorks Therapeutics, Inc. (14.45%), Apogee Therapeutics, Inc. (13.11%), Arcellx, Inc. (9.85%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), Nuance Communications, Inc. ($2.18 billion), and Palo Alto Networks, Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling CBPO is an investing strategy that aims to generate trading profit from China Biologic Products as its price is falling. CBPO shares are trading up $1.98 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for China Biologic Products occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CBPO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBPO, twice per month. The most recent reporting period available is April, 15 2021.